Protein profiling of microdomains purified from renal cell carcinoma and normal kidney tissue samples

F. Raimondo, L. Morosi, C. Chinello, R. Perego, C. Bianchi, G. Albo, S. Ferrero, F. Rocco, F. Magni, M. Pitto

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Renal cell carcinoma (RCC) is representing about 3% of all adult cancers. A promising strategy for cancer biomarker discovery is subcellular comparative proteomics, allowing enriching specific cell compartments and assessing differences in protein expression patterns. We investigated the proteomic profile of a peculiar RCC subcellular compartment, plasma membrane microdomains (MD), involved in cell signalling, transport, proliferation and in many human diseases, such as cancer. Subcellular fractions were prepared by differential centrifugation from surgical samples of RCC and adjacent normal kidney (ANK). MD were isolated from plasma-membrane-enriched fractions after Triton X-100 treatment and sucrose density gradient ultracentrifugation. MD derived from RCC and ANK tissues were analyzed after SDS-PAGE separation by LC-ESI-MS/MS. We identified 93 proteins from MD isolated from RCC tissue, and 98 proteins from ANK MD. About 70% of the identified proteins are membrane-associated and about half of these are known as microdomain-associated. GRAVY scores assignment shows that most identified proteins (about 70%) are in the hydrophobic range. We chose a panel of proteins to validate their differential expression by WB. In conclusion, our work shows that RCC microdomain proteome is reproducibly different from ANK, and suggests that mining into such differences may support new biomarker discovery.

Original languageEnglish
Pages (from-to)1007-1016
Number of pages10
JournalMolecular BioSystems
Volume8
Issue number4
DOIs
Publication statusPublished - Mar 2012

Fingerprint

Renal Cell Carcinoma
Kidney
Proteins
Proteomics
Cell Membrane
Membrane Microdomains
Subcellular Fractions
Ultracentrifugation
Octoxynol
Proteome
Tumor Biomarkers
Centrifugation
Sucrose
Polyacrylamide Gel Electrophoresis
Neoplasms
Membrane Proteins
Biomarkers

ASJC Scopus subject areas

  • Biotechnology
  • Molecular Biology

Cite this

Protein profiling of microdomains purified from renal cell carcinoma and normal kidney tissue samples. / Raimondo, F.; Morosi, L.; Chinello, C.; Perego, R.; Bianchi, C.; Albo, G.; Ferrero, S.; Rocco, F.; Magni, F.; Pitto, M.

In: Molecular BioSystems, Vol. 8, No. 4, 03.2012, p. 1007-1016.

Research output: Contribution to journalArticle

Raimondo, F, Morosi, L, Chinello, C, Perego, R, Bianchi, C, Albo, G, Ferrero, S, Rocco, F, Magni, F & Pitto, M 2012, 'Protein profiling of microdomains purified from renal cell carcinoma and normal kidney tissue samples', Molecular BioSystems, vol. 8, no. 4, pp. 1007-1016. https://doi.org/10.1039/c2mb05372a
Raimondo, F. ; Morosi, L. ; Chinello, C. ; Perego, R. ; Bianchi, C. ; Albo, G. ; Ferrero, S. ; Rocco, F. ; Magni, F. ; Pitto, M. / Protein profiling of microdomains purified from renal cell carcinoma and normal kidney tissue samples. In: Molecular BioSystems. 2012 ; Vol. 8, No. 4. pp. 1007-1016.
@article{6bfe5558b9c745abbac3f895892edba4,
title = "Protein profiling of microdomains purified from renal cell carcinoma and normal kidney tissue samples",
abstract = "Renal cell carcinoma (RCC) is representing about 3{\%} of all adult cancers. A promising strategy for cancer biomarker discovery is subcellular comparative proteomics, allowing enriching specific cell compartments and assessing differences in protein expression patterns. We investigated the proteomic profile of a peculiar RCC subcellular compartment, plasma membrane microdomains (MD), involved in cell signalling, transport, proliferation and in many human diseases, such as cancer. Subcellular fractions were prepared by differential centrifugation from surgical samples of RCC and adjacent normal kidney (ANK). MD were isolated from plasma-membrane-enriched fractions after Triton X-100 treatment and sucrose density gradient ultracentrifugation. MD derived from RCC and ANK tissues were analyzed after SDS-PAGE separation by LC-ESI-MS/MS. We identified 93 proteins from MD isolated from RCC tissue, and 98 proteins from ANK MD. About 70{\%} of the identified proteins are membrane-associated and about half of these are known as microdomain-associated. GRAVY scores assignment shows that most identified proteins (about 70{\%}) are in the hydrophobic range. We chose a panel of proteins to validate their differential expression by WB. In conclusion, our work shows that RCC microdomain proteome is reproducibly different from ANK, and suggests that mining into such differences may support new biomarker discovery.",
author = "F. Raimondo and L. Morosi and C. Chinello and R. Perego and C. Bianchi and G. Albo and S. Ferrero and F. Rocco and F. Magni and M. Pitto",
year = "2012",
month = "3",
doi = "10.1039/c2mb05372a",
language = "English",
volume = "8",
pages = "1007--1016",
journal = "Molecular BioSystems",
issn = "1742-206X",
publisher = "Royal Society of Chemistry",
number = "4",

}

TY - JOUR

T1 - Protein profiling of microdomains purified from renal cell carcinoma and normal kidney tissue samples

AU - Raimondo, F.

AU - Morosi, L.

AU - Chinello, C.

AU - Perego, R.

AU - Bianchi, C.

AU - Albo, G.

AU - Ferrero, S.

AU - Rocco, F.

AU - Magni, F.

AU - Pitto, M.

PY - 2012/3

Y1 - 2012/3

N2 - Renal cell carcinoma (RCC) is representing about 3% of all adult cancers. A promising strategy for cancer biomarker discovery is subcellular comparative proteomics, allowing enriching specific cell compartments and assessing differences in protein expression patterns. We investigated the proteomic profile of a peculiar RCC subcellular compartment, plasma membrane microdomains (MD), involved in cell signalling, transport, proliferation and in many human diseases, such as cancer. Subcellular fractions were prepared by differential centrifugation from surgical samples of RCC and adjacent normal kidney (ANK). MD were isolated from plasma-membrane-enriched fractions after Triton X-100 treatment and sucrose density gradient ultracentrifugation. MD derived from RCC and ANK tissues were analyzed after SDS-PAGE separation by LC-ESI-MS/MS. We identified 93 proteins from MD isolated from RCC tissue, and 98 proteins from ANK MD. About 70% of the identified proteins are membrane-associated and about half of these are known as microdomain-associated. GRAVY scores assignment shows that most identified proteins (about 70%) are in the hydrophobic range. We chose a panel of proteins to validate their differential expression by WB. In conclusion, our work shows that RCC microdomain proteome is reproducibly different from ANK, and suggests that mining into such differences may support new biomarker discovery.

AB - Renal cell carcinoma (RCC) is representing about 3% of all adult cancers. A promising strategy for cancer biomarker discovery is subcellular comparative proteomics, allowing enriching specific cell compartments and assessing differences in protein expression patterns. We investigated the proteomic profile of a peculiar RCC subcellular compartment, plasma membrane microdomains (MD), involved in cell signalling, transport, proliferation and in many human diseases, such as cancer. Subcellular fractions were prepared by differential centrifugation from surgical samples of RCC and adjacent normal kidney (ANK). MD were isolated from plasma-membrane-enriched fractions after Triton X-100 treatment and sucrose density gradient ultracentrifugation. MD derived from RCC and ANK tissues were analyzed after SDS-PAGE separation by LC-ESI-MS/MS. We identified 93 proteins from MD isolated from RCC tissue, and 98 proteins from ANK MD. About 70% of the identified proteins are membrane-associated and about half of these are known as microdomain-associated. GRAVY scores assignment shows that most identified proteins (about 70%) are in the hydrophobic range. We chose a panel of proteins to validate their differential expression by WB. In conclusion, our work shows that RCC microdomain proteome is reproducibly different from ANK, and suggests that mining into such differences may support new biomarker discovery.

UR - http://www.scopus.com/inward/record.url?scp=84858049725&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84858049725&partnerID=8YFLogxK

U2 - 10.1039/c2mb05372a

DO - 10.1039/c2mb05372a

M3 - Article

C2 - 22159573

AN - SCOPUS:84858049725

VL - 8

SP - 1007

EP - 1016

JO - Molecular BioSystems

JF - Molecular BioSystems

SN - 1742-206X

IS - 4

ER -